Can immunotherapy treat neurodegeneration?

Science

Volumn 357, Issue 6348, 2017, Pages 254-255

  Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

BRAIN; CANCER; CELLS AND CELL COMPONENTS; IMMUNE SYSTEM; NERVOUS SYSTEM DISORDER; NEUROLOGY; PROTEIN;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CANCER IMMUNOTHERAPY; CELL INFILTRATION; DISEASE COURSE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; BRAIN; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; BRAIN; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; NEOPLASMS;

EID: 85025701261     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aai8231     Document Type: Short Survey

References (16)

1. ADAPT-FS Research Group, Alzheimers Dement. 11, 216 (2015).
2. Y. Ziv et al., Nat. Neurosci. 9, 268 (2006).
3. G. Moalem et al., Nat. Med. 5, 49 (1999).
4. R. Shechter et al., Immunity 38, 555 (2013).
5. N. C. Derecki et al., J. Exp. Med. 207, 1067 (2010).
6. A. Louveau et al., Nature 523, 337 (2015).
7. G. Naert, S. Rivest, J. Mol. Cell Biol. 5, 284 (2013).
8. T. Town et al., Nature Med. 14, 681 (2008).
9. S. E. Marsh et al., Proc. Natl. Acad. Sci. U.S.A. 113, E1316 (2016).
10. K. Baruch et al., Science 346, 89 (2014).
11. K. Baruch et al., Nat. Commun. 6, 7967 (2015).
12. S. D. Mesquita et al., Brain Behav. Immun. 49, 280 (2015).
13. D. M. Pardoll, Nat. Rev. Cancer 12, 252 (2012).
14. K. Baruch et al., Nat. Med. 22, 135 (2016).
15. H. Keren-Shaul et al., Cell 169, 1276 e1217 (2017).
16. See supplementary materials for additional references.